Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Alzheimers Disease & Parkinsonism received 3123 citations as per Google Scholar report
Journal Impact Factor 2.04*
; 3.42* (5 Year Journal Impact Factor)
Submit manuscript at https://www.scholarscentral.org/submission/alzheimers-disease-parkinsonism.html or send as an e-mail attachment to the Editorial Office at submissions@omicsonline.com
If you are interested in publishing with us or have any questions, please feel free to contact us directly on WhatsApp .
NLM ID: 101587593
Index Copernicus Value: 84.15
Alzheimer's Medical Journals aims to bridge knowledge gaps separating traditional fields of dementia research. Alzheimer's Journal publishes peer reviewed articles with highest impact factor offers Open Access option to meet the needs of authors and maximize article visibility.
Alzheimer’s disease also called as Dementia generally develops among the old age, leading to loss of memory and cognitive functioning such as thinking, remembering and reasoning and behavioral abilities that disturbs the daily routine of the affected people. Parkinsonism is a neurodegenerative disease with symptoms like tremor, rigidity and postural problems.
The Journal of Alzheimer Disease & Parkinsonism (JADP) is the best open access, Peer reviewed journal that includes a wide range of fields in this discipline including Neuroimaging Techniques, Oxidative Stress-Induced Neuron Toxicity, Reperfusion Injury, Neurobiology, CNS Tumor Stem Cells, Down Syndrome, Neuropathology, Neurodegenerative Disorders, Oxidative Stress, Alzheimer′s Patients etc to create a platform for the authors to make their contributions towards the scholarly journals and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing.
This Scholarly Publishing, Open Access journal aims to publish the most reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available online without any restrictions or subscriptions to the researchers worldwide.
It is a Neurodegenerative disorder. The symptoms of this disease is it damage the brain results in memory loss,difficulty in remembering information and learning.The symptoms are different according to the individuals and area of brain affected. Alzheimers is the high leading cause of death in the world.Depending on the age and health conditions alzheimers patients can survive 8-15 yrs after symptoms become noticeable.There is no specific cause of Alzheimers but researchers they believe that Environmental factors and genetic factors may induce abnormal process in brain that leads to Alzheimers.
Related Journals of Alzheimer’s Disease
Journal of Dementia & Mental health, Alzheimer's & Dementia, Journal of Alzheimer's Disease, Current Alzheimer's Disease, Neuropsychological Rehabilitation, Rehabilitation Psychology, Journal of the Alzheimer's Association, International Journal of Parkinson's Disease, Current Alzheimer Research, Alzheimer's Research & Therapy, International journal of Alzheimer's Disease & associated disorders, Parkinsonism & Related Disorders, Advances in Parkinson's. Disease
Parkinson's disease is a disorder of the nervous system that affects your movement and mental ability. It develops gradually, shaking in thumb, chin or lip, moments during sleeping,feeling dizzy,low blood pressure. Parkinson's disease can't be cured. In some cases, doctors may suggest medication, Pharmacology treatment and surgery to re certain regions of your brain . anti-Parkinson disease medication treatment is good control of parkinson diesease for 4-5 yrs. Physiothery is also a good treatment to improve your muscle strength.
Related Journals of Parkinson
Journal of Gerontology & Geriatric Research, Journal of Dementia & Mental health, Parkinson's Disease, Journal of Parkinson's Disease, Focus on Parkinson's Disease, Parkinson Model, International Journal of Parkinson's Disease, Advances in Parkinson's Disease, Journal of Parkinson's Disease, Parkinsonism & Related Disorders,
It is a condition of loss of function of central nervous system and loss of muscle coordination leading to cell death. Degenerative disorders are paralysis, Parkinson, alzheimers and dementia. Most of the degenerative diseases have not any treatment. These neurodegenerative disease causes are toxins, chemicals, genetic and viruses. Treatment like medication may improve the pain relief and improve mobility. These diseases are mainly associated with metabolic deficiencies and by infectious agents.
Related Journals of Degenerative Disorders
International Journal of Neurorehabilitation, Journal of Rehabilitation Medicine, Neuropsychological Rehabilitation, Neurorehabilitation, Behavioral Interventions, Applied Neuropsychology Substance Abuse Treatment, Neurodegenerative Diseases, Journal of Neurological Disorders, Journal of Neurology and Neuroscience.
Recent studies indicating that therappeutic drugs and gene therapy are advanced techniques to control alzheimers disease Genomics therapy is most recent advances in AD research, when the disease was first described. Researchers are looking for new therapy treatments for dementia. Currently, there is no cure for Alzheimer's But these alzheimers products may show a good results to cure memory loss.
Related Journals of Advances in Alzheimers Therapy
Journal of Dementia & Mental health, Rehabilitation in Movement Disorders, Stress Alzheimers, Neuron, American Journal of Occupational Therapy, Journal of Alzheimer's & Dementia, Journal of the Alzheimer's Association, Journal of Alzheimer's Disease, Alzheimer's Research & Therapy, Journal of Alzheimer's Disease and Other Dementias, International journal of Alzheimer's Disease & associated disorders, International Journal of Alzheimer’s Disease, Advances in Alzheimer's Disease, American Journal of Alzheimer’s Disease, Current Alzheimer Research.
Drug and non-Drug treatment for Alzheimer's disease is important to cure some behavioral symptoms. Drugs like Acetylcholinesterase Inhibitors and NMDA receptor antagonists used to treat Alzheimers disease control Non drug therapy like art therapy,aroma therapy and religious activites may control emotional and stress reactions.Today Herbal medicine,dietary supplements and medical foods are used as alternative treatment for Alzheimers Disease.
Related Journals of Alzheimers Medicine
Journal of Dementia & Mental health, Gerontology & Geriatric Research Journal, Canadian Journal of Occupational Therapy, Occupational Therapy in Mental Health, Occupational Therapy in Health Care, Occupational Therapy International, Physical & Occupational Therapy in Geriatrics, Journal of Alzheimer's & Dementia, Journal of the Alzheimer's Association, Journal of Alzheimer's Disease, Alzheimer's Research & Therapy, Journal of Alzheimer's Disease and Other Dementias, International journal of Alzheimer's Disease & associated disorders, International Journal of Alzheimer’s Disease, Advances in Alzheimer's Disease, American Journal of Alzheimer’s Disease, Current Alzheimer Research.
some products are available in the market to control alzheimers disease.These Products are Color Cards Activity , Color-Coded Therapy are designed to stimulate the mind and sense. Alzheimers games and puzzles and eating dishes are available in the market for brain activity. Treatment with drug, non drug or medication and surgery sometimes shows side effetcs.But these alzheimers products may show a good results to cure memory loss.
Related Journals of Alzheimers Products & Market Analysis
Gerontology & Geriatric Research Journal, Journal of Dementia & Mental health, Journal of Neurosurgical Anesthesiology, Intensive Care Medicine, Current Opinion in Critical Care, Acta Neurochirurgica, Journal of The Neurological Sciences, Journal of Neurology, Current Alzheimer Research, American Journal of Alzheimer’s Disease, Advances in Alzheimer's Disease, International Journal of Alzheimer’s Disease, International journal of Alzheimer's Disease & associated disorders, Journal of Alzheimer's Disease and Other Dementias, Alzheimer's Research & Therapy, Journal of Alzheimer's Disease, Journal of the Alzheimer's Association, Journal of Alzheimer's & Dementia.
Recent studies indicating that therappeutic drugs and gene therapy are advanced techniques to control alzheimers disease. Genomics therapy is most recent advances in Alzheimers Disease research, when the disease was first described. Researchers are looking for new therapy treatments for dementia. Currently, there is no cure for Alzheimer's But these alzheimers products may show a good results to cure memory loss.
Related Journals of Alzheimers Symptoms
Journal of Dementia & Mental health, Journal of Alzheimers Disease & Parkinsonism, Journal of Alzheimer's Disease, Current Alzheimer's Disease, Onset Alzheimer's, Oxidative Stress and Neurodegenerative Disorders.
Biomarkers kit is available to diagnise the presence and absence of alzheimers disease. During alzherimers diagnosis, the doctor will test series of test regarding patient family history, brain condition, medical history and cause of your symptoms. We can conform this disease by lab test,neurological exam,mental status testing,neuropsychological testing,brain imaging. Brain Image mainly used to diagnise the brain abnormalities such stroke, and trauma. Researchers are developing new diagnostic methods to know the alzherimers disease.
Related Journals of Diagnostic Alzheimer
International Neurorehabilitation Journal, Journal of Gerontology & Geriatric Research, NeuroRehabilitation, Neurorehabilitation and Neural Repair, Developmental Neurorehabilitation, Journal of NeuroEngineering and Rehabilitation.
The treatments used to cure Parkinson disease are medication, drug therapy, surgery, physiotherapy, speech and language therapy and occupational therapy. Medication treatment is popular treatment to cure symptoms of Parkinson. Treatments like drug treatment, surgery and brain image can give side effects. The most common treatment used to control Parkinson is stimulation of Dopamine receptors. Repairing the brain cells treatment is advanced treatment for Parkinson disease.
Related Journals of Advanced Parkinson Treatment
Journal of Dementia & Mental health, Gerontology & Geriatric Research Journal, Parkinson's Disease, Journal of Parkinson's Disease, Focus on Parkinson's Disease, American Journal of Occupational Therapy, Canadian Journal of Occupational Therapy.
Parkinson's disease is a disorder of the nervous system that affects your movement and mental ability. Researchers are looking for new therapy treatments for Parkinsonism is replace lost dopamine by using drugs that will work like dopamine. Scientists are working with various kinds of genes to treat Parkinson. Gene Therapy is a potential technique to stop the progression of Parkinson disease. For example, gene therapy is used to change the function of certain cells behavior to stop them that producing harmful or to make them do something that is beneficial.
Related Journals of Parkinsonism Gene Therapy
Gerontology & Geriatric Research Journal, Parkinson Model,parkinson Model, Parkinson Related Disorders, Parkinson Review, Physical & Occupational Therapy in Geriatrics.
Parkinson stages include Initial stage, middle stage and Final stage. Many treatments that can help to cure Parkinson symptoms. These treatments are medicines, home treatment, surgery, speech therapy, physical therapy and occupational therapy. Medicines like Dopamine antagonist are common for Parkinson treatment. Home treatment like exercise,eating habits can cure symptoms. Brain surgery also good treatment to prevent Parkinson.
Related Journals of Parkinsonism Stages and Treatment
Journal of Gerontology & Geriatric Research, International Journal of Neurorehabilitation, Archives of Physical Medicine and Rehabilitation, Clinical Rehabilitation, Topics in Stroke Rehabilitation, Disability and Rehabilitation, Cerebrovascular Diseases, Journal of Stroke & Cerebrovascular Diseases.
Drugs like asneuroleptic drugs, clozapine (Clozaril) and quetiapine (Seroquel), and to a lesser extent olanzapine (Zyprexa) and risperidone (Risperdal) may induce the parkinsonism.Anti sickness drugs like domperidone (Motilium) or ondansetron (Zofran) and neuroleptic drugs can be drug-induced parkinsonism. A number of other drugs also cause drug-induced parkinsonism but the cause is unknown.Some drugs like Amiodarone, used to treat heart problems but it causes tremor some people to develop Parkinson’s-like symptoms. Sodium valproate agent used to treat epilepsy , lithium and depression, but commonly cause tremor which leads to parkinson.
Related Journals of Parkinsonism Diagnosis
Journal of Dementia & Mental health, International Journal of Neurorehabilitation, Advances in Artificial Neural Systems, Experimental Brain Research, Neuroscience and Behavioral Physiology, Journal of Neurocytology, Acta Neuropathologica.
Stem cell treatments for Parkinson's are still in the Initial stages of development. stem cell treatment is advanced treatment for many diseases like Alzheimers,parkinson and other neurological disorders.Stem cells have the ability to change into other type of cells. Because stem cells they can change into neurons,bone,muscle and other type of cells. Many researchers they believe that these stem cells have the ability to cure many diseases. Researchers are using stem cells to grow dopamine-producing nerve cells in the invitro condition, and these Dopamine producing nerve cells can transplanted into patients.
Related Journals of Stem cell Treatment Parkinson
Journal of Dementia & Mental health, Cell Stem Cell, Stem Cells and Development, Stem Cell Reviews and Reports, Current Stem Cell Research and Therapy, Stem Cell Research, Stem Cell Research and Therapy, Stem Cells International, Stem cells Translational Medicine.
*2023 Journal Impact Factor was established by dividing the number of articles published in 2021 and 2022 with the number of times they are cited in 2023 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2021 and 2022, and 'Y' is the number of times these articles were cited in indexed journals during 2023 then, journal impact factor = Y/X
Fast Editorial Execution and Review Process (FEE-Review Process):
Journal of Alzheimers Disease & Parkinsonism is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals